Impact of tumour size on axillary involvement and distant dissemination in breast cancer

British Journal of Cancer

Volumn 101, Issue 6, 2009, Pages 902-907

  Koscielny, S ^a,b   Arriagada, R ^a,c   Adolfsson, J ^c   Fornander, T ^c   Bergh, J ^c  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSERM   (France)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast cancer; Parametric models; Prognosis; Tumour size

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADJUVANT THERAPY; ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST TUMOR; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; FRANCE; GEOGRAPHIC DISTRIBUTION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; RISK ASSESSMENT; SWEDEN; TUMOR VOLUME;

AXILLA; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LYMPH NODES; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS;

EID: 70249149239     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605221     Document Type: Article

References (19)

1. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ (2005) Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353: 1784-1792
2. Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status and survival in 24 740 breast cancer cases. Cancer 63: 181-187
3. Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Collaborators (2006) The impact of mammography and adjuvant therapy on U.S. breast cancer mortality (1975-2000): Collective Results from the Cancer Intervention and Surveillance Modeling Network. J Natl Cancer Inst Monogr 36: 1-126
4. Early Breast Cancer Trialists' Collaborative Group (1998a) Polychemo-therapy for early breast cancer: an overview of the randomised trials. Lancet 352: 930-942
5. Early Breast Cancer Trialists' Collaborative Group (1998b) Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351: 1451-1467
6. Frisell J, Lidbrink E, Hellstrom L, Rutqvist LE (1997) Follow-up after 11 years: update of mortality results from the Stockholm mammographic screening trial. Breast Cancer Res Treat 45: 263-270
7. Kemetli L, Rutqvist LE, Jonsson H, Nyström L, Lenner P, Törnberg S (2009) Temporal trends in the use of adjuvant systemic therapy in breast cancer: a population based study in Sweden 1976-2005. Acta Oncol 48(1): 59-66
8. Koscielny S, Lê MG, Tubiana M (1989) The natural history of human breast cancer. The relationship between involvement of axillary lymph nodes and the initiation of distant metastases. Br J Cancer 59: 775-789
9. Koscielny S, Tubiana M, Lé MG, Valleron A-J, Mouriesse H, Sarrazin D (1984) Breast cancer: the relationship between the size of the primary tumor and the probability of metastatic dissemination. Br J Cancer 49: 709-715
10. Koscielny S, Tubiana M, Valleron A-J (1985) A simulation model of the natural history of human breast cancer. Br J Cancer 52: 515-524
11. Michaelson J, Silverstein M, Sgroi D, Cheongsiatmoy JA, Taghian A, Powell S, Hughes K, Comegno A, Tanabe KK, Smith B (2003a) The effect of tumor size and lymph node status on breast carcinoma lethality. Cancer 98: 2133-2143
12. Michaelson JS, Satija S, Kopans D, Moore R, Silverstein M, Comegno A, Hughes K, Taghian A, Powell S, Smith B (2003b) Gauging the impact of breast carcinoma screening in terms of tumor size and death rate. Cancer 98: 2114-2124
13. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE (2002) Long term effects of screening mammography: updated overview of the Swedish randomized trials. Lancet 359: 909-919
14. Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000: the global picture. Eur J Cancer 37: S4-S66
15. Ravdin PM, Siminoff LA, Davis GJ, Mercer MB, Hewlett J, Gerson N, Parker HL (2001) Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 19: 980-991
16. Shen Y, Yang Y, Inoue LY, Munsell MF, Miller AB, Berry DA (2005) Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J Natl Cancer Inst 97: 1195-1203
17. Törnberg S, Kemetli L, Lynge E, Olsen A, Hofvind S, Wang H, Anttila A, Hkama M, Nyström L (2006) Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmes. Acta Oncol 45: 528-535
18. Törnberg S, Kemetli L, Svane G, Rosen M, Stenbeck M, Nyström L (2005) Pattern of participation in a cohort aged 50-60 years at first invitation to the service-screening programme with mammography in Stockholm county, Sweden. Prev Med 41: 728-733
19. Tubiana M, Koscielny S (1990) The natural history of breast cancer: implications for a screening strategy. Int J Radiat Oncol Biol Phys 19: 1117-1120